BioCentury
ARTICLE | Clinical News

DM-1992: Phase II data

November 12, 2012 8:00 AM UTC

Top-line data from an open-label, crossover, U.S. Phase II trial in 34 advanced PD patients with motor fluctuations showed that twice-daily DM-1992 met the primary endpoint of reducing mean daily "off...